Novartis Technical Analysis

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>NO</div>
NVS -- USA Stock  

Report: 21st of July 2020  

As of the 10th of July, Novartis secures the risk adjusted performance of 0.0462, downside deviation of 1.41, and mean deviation of 1.07. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novartis AG, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Novartis, which can be compared to its peers in the industry. Please verify Novartis AG jensen alpha and semi variance to decide if Novartis AG is priced some-what accurately, providing market reflects its recent price of 87.01 per share. Given that Novartis AG has jensen alpha of 0.0516, we recommend you to check Novartis's last-minute market performance to make sure the company can sustain itself at a future point.

Search Technical Analysis

Target PriceAdvice# of Analysts
Novartis AG current and past analyst recommendations published by a number of research institutions as well as average analyst consensus. Most Novartis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Novartis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Novartis AG, talking to its executives and customers, or listening to Novartis conference calls.
Novartis Analyst Advice Details
Novartis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Novartis technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Novartis trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Novartis AG Technical Analysis

Time Period
  Portfolio Suggestion    
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Novartis AG volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.

Novartis AG Trend Analysis

Use this graph to draw trend lines for Novartis AG. You can use it to identify possible trend reversals for Novartis as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Novartis price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Novartis Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Novartis AG applied against its price change over selected period. The best fit line has a slop of   0.028043  , which may imply that Novartis AG will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 29.74, which is the sum of squared deviations for the predicted Novartis price change compared to its average price change.

About Novartis Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Novartis AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Novartis AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Novartis AG stock first instead of the macroeconomic environment surrounding Novartis AG . By analyzing Novartis's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Novartis's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Novartis specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2017 2019 (projected)
Book Value per Share31.2424.0
Asset Turnover0.330.37

Novartis July 10, 2020 Technical Indicators

Most technical analysis of Novartis stock help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Novartis from various momentum indicators to cycle indicators. When you analyze Novartis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators
Risk Adjusted Performance0.0462
Market Risk Adjusted Performance(0.18)
Mean Deviation1.07
Semi Deviation1.33
Downside Deviation1.41
Coefficient Of Variation3692.77
Standard Deviation1.4
Information Ratio(0.09)
Jensen Alpha0.0516
Total Risk Alpha(0.09)
Sortino Ratio(0.09)
Treynor Ratio(0.19)
Maximum Drawdown7.31
Value At Risk(2.03)
Potential Upside2.25
Downside Variance1.99
Semi Variance1.77
Expected Short fall(1.11)

Novartis July 10, 2020 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Novartis stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution  10,126  
Daily Balance Of Power (0.45)  
Rate Of Daily Change  1.00  
Day Median Price  86.94  
Day Typical Price  86.96  
Price Action Indicator (0.09)  
Additionally, see Stocks Correlation. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page